Aurobindo FDA Friday, September 25, 2026 +0.20 Positive

FDA Approves METRONIDAZOLE VAGINAL GEL — Aurobindo Pharma Limited

Aurobindo Pharma Limited received green light from the FDA to manufacture and market its generic Metronidazole Vaginal Gel (ANDA 218485), a move that is poised to bolster inventory and increase competition within the vaginal infection treatment market. This approval will likely provide a commercial boost for the Indian generic manufacturer as it enters a sector characterized by steady consumption and shifting patient preferences.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed